Stocks to Watch: SpaceX, AT&T, Verizon, T-Mobile, Alignment Healthcare, CVS Health
By Elias Schisgall
SpaceX bought a portfolio of spectrum licenses from Grain Management. SpaceX shares gained 2.8%, to $165.04, while AT&T, Verizon, and T-Mobile US all saw their stocks drop about 6.6% after hours.
Alignment Healthcare said one of its 2027 Medicare Advantage plans received a 3.5-star rating from the Centers for Medicare & Medicaid Services. Shares dropped 23%, to $6.70, after Thursday's closing bell.
CVS Health's health-insurance business, Aetna, said more than 69% of its Medicare Advantage members are in 2027 plans that received ratings of at least four stars. The stock slid 3%, to $85.16, in after-hours trading.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
October 08, 2026 19:05 ET (23:05 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
3 Stocks to Invest In With More Room to Run
